Search Results 621-630 of 18158 for Lymphocytic leukemia

  1. Publications - Allison M. Angeli, M.D. - Mayo Clinic

    Webb LM, Kenderian SS, Angeli AM, Howard MT, Wijdicks EF. Chronic Lymphocytic Leukemia Infiltrating in the Brain. Cureus. 2024 Nov; 16 (11):e74080 Epub 2024 ...

  2. Rituximab-arrx (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab-arrx injection is also used together with other medicines (eg, fludarabine and cyclophosphamide) to treat chronic lymphocytic leukemia (CLL).

  3. Hematology - Doctors - Mayo Clinic

    Acute lymphocytic leukemia, Myelodysplastic syndromes, Acute myelogenous leukemia, Chronic myelomonocytic leukemia, Bon...e marrow failure syndromes ...

  4. Clinical trials - Oncology (Medical)

    ... lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring ...

  5. Follicular lymphoma - Doctors and departments - Mayo Clinic

    CAR-T cell therapy, Multiple myeloma, Leukemia, Chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, Macroglobu...linemia, Chronic myelogenous leukemia ...

  6. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

    Acute Leukemia/Myelodysplasia Group · Bone Marrow Transplant Program ... Anyone have chronic lymphocytic leukemia (CLL)?. 79 Replies Sat, Jun 07, 2025.

  7. Clinical trials - Oncology (Medical)

    ... lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring ...

  8. Advancement in CAR-T cell therapy for resistant B cell cancers - Mayo Clinic

    ... lymphocytic leukemia. The BAFF-R protein is associated with tumor growth, and this innovative therapy is designed to empower the immune system to combat ...

  9. Clinical trials - Oncology (Medical)

    ... lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring ...

  10. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

    Clinical Trials · A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) · More about ...